Silvia Ortega-Gutiérrez

Prof. Dr. Silvia Ortega-Gutiérrez

Organic Chemistry Department, School of Chemistry Universidad Complutense de Madrid, E-28040 Madrid, Spain.
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2003 in Science
Verified
Journal Article
Closed access
PDF file
GMGiovanni Marsicano
Giovanni Marsicano
SGSharon Goodenough
Sharon Goodenough
KMKrisztina Monory
Krisztina Monory
HHHeike Hermann
Heike Hermann
MEMatthias Eder
Matthias Eder
BLBeat Lutz
Beat Lutz
Abnormally high spiking activity can damage neurons. Signaling systems to protect neurons from the consequences of abnormal discharge activity have been postulated. We generated conditional mutant mice that lack expression of the cannabinoid receptor type 1 in principal forebrain neurons but not in adjacent inhibitory interneurons. In mutant mice,the excitotoxin kainic acid (KA) induced excessive seizures in vivo. The threshold to KA-induced neuronal excitation in vitro was severely reduced in hippocampal pyramidal neurons of mutants. KA administration rapidly raised hippocampal levels of anandamide and induced protective mechanisms in wild-type principal hippocampal neurons. These protective mechanisms could not be triggered in mutant mice. The endogenous cannabinoid system thus provides on-demand protection against acute excitotoxicity in central nervous system neurons.

4 March 2012 in Nature Neuroscience
Verified
Journal Article
Closed access
GBGiovanni Bénard
Giovanni Bénard
FMFederico Massa
Federico Massa
NPNagore Puente
Nagore Puente
JLJoana Lourenço
Joana Lourenço
LBLuigi Bellocchio
Luigi Bellocchio
GMGiovanni Marsicano
Giovanni Marsicano

1 July 2013 in International Journal of Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
ACAlline C. Campos
Alline C. Campos
ZOZaira Ortega
Zaira Ortega
JPJavier Palazuelos
Javier Palazuelos
MFManoela V. Fogaça
Manoela V. Fogaça
DADaniele C. Aguiar
Daniele C. Aguiar
FGFrancisco S. Guimarães
Francisco S. Guimarães
Cannabidiol (CBD), the main non-psychotomimetic component of the plant Cannabis sativa, exerts therapeutically promising effects on human mental health such as inhibition of psychosis, anxiety and depression. However, the mechanistic bases of CBD action are unclear. Here we investigate the potential involvement of hippocampal neurogenesis in the anxiolytic effect of CBD in mice subjected to 14 d chronic unpredictable stress (CUS). Repeated administration of CBD (30 mg/kg i.p., 2 h after each daily stressor) increased hippocampal progenitor proliferation and neurogenesis in wild-type mice. Ganciclovir administration to GFAP-thymidine kinase (GFAP-TK) transgenic mice, which express thymidine kinase in adult neural progenitor cells, abrogated CBD-induced hippocampal neurogenesis. CBD administration prevented the anxiogenic effect of CUS in wild type but not in GFAP-TK mice as evidenced in the novelty suppressed feeding test and the elevated plus maze. This anxiolytic effect of CBD involved the participation of the CB1 cannabinoid receptor, as CBD administration increased hippocampal anandamide levels and administration of the CB1–selective antagonist AM251 prevented CBD actions. Studies conducted with hippocampal progenitor cells in culture showed that CBD promotes progenitor proliferation and cell cycle progression and mimics the proliferative effect of CB1 and CB2 cannabinoid receptor activation. Moreover, antagonists of these two receptors or endocannabinoid depletion by fatty acid amide hydrolase overexpression prevented CBD-induced cell proliferation. These findings support that the anxiolytic effect of chronic CBD administration in stressed mice depends on its proneurogenic action in the adult hippocampus by facilitating endocannabinoid-mediated signalling.

1 October 2015 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
MMM. Mecha
M. Mecha
AFA. Feliú
A. Feliú
FCFrancisco J Carrillo-Salinas
Francisco J Carrillo-Salinas
ARA. Rueda-Zubiaurre
A. Rueda-Zubiaurre
Silvia Ortega-GutiérrezSilvia Ortega-Gutiérrez
Silvia Ortega-Gutiérrez
CGC. Guaza
C. Guaza

9 May 2016 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
JMJose Luis López-Sendón Moreno
Jose Luis López-Sendón Moreno
JCJuan García Caldentey
Juan García Caldentey
PCPatricia Trigo Cubillo
Patricia Trigo Cubillo
CRCarolina Ruiz Romero
Carolina Ruiz Romero
GRGuillermo García Ribas
Guillermo García Ribas
JPJusto García De Yébenes Prous
Justo García De Yébenes Prous

1 November 2018 in Biochemical Pharmacology
Verified
Journal Article
Closed access
AGAna Gil-Ordóñez
Ana Gil-Ordóñez
MMMar Martin-Fontecha
Mar Martin-Fontecha
Silvia Ortega-GutiérrezSilvia Ortega-Gutiérrez
Silvia Ortega-Gutiérrez
María L. López-RodríguezMaría L. López-Rodríguez
María L. López-Rodríguez